KKR Group Co Inc

KKR & Co Inc’s bold moves—high‑growth healthcare stakes, strategic exits, and premium preferred stock—showcase how the firm keeps building value and staying ahead of market volatility.

KKR’s rapid shift from biotech to U.S. garage‑door services, insurance exits, credit hires, and an AI JV shows its aggressive diversification – but regulatory scrutiny looms.

KKR’s latest moves—$10B AI JV, $2B garage‑door buy, $17B USI sale, and a record $250M pre‑merger fine—show how the firm’s tech push and portfolio shrewdness fuel strong investor returns.

KKR sells USI Insurance Services to Aon for $17 billion, freeing cash to invest in infrastructure, ESG projects and high‑growth tech, boosting shareholder value.

KKR expands into Japan’s beauty sector by acquiring Ci FLAVORS, adding a scalable, consumer‑direct platform and e‑commerce assets to its global portfolio.

KKR’s $1.4B Medicover India deal expands its healthcare footprint, adding 24 hospitals, 4,800 beds and a high‑growth Indian patient base.

KKR’s bold 2026 strategy—spinning a $1.4B Medicover India deal, a $500M renewable InvIT, and $2.45B financing—boosts growth, returns, and investor confidence.

KKR’s latest moves: near‑finalizing a $127/share acquisition of Integer Holdings, investing $250 M in a Blue Owl insurer, and buying UK logistics assets – all fueling record PE exits and a 2030 earnings target of $1.1 B.

KKR exits LCY, appoints former Manulife CEO, and boosts infrastructure bets to sharpen focus on high‑yield, low‑risk assets and grow its insurance reach.

KKR’s latest moves blend private‑equity strength with new data‑center, renewable‑energy, and telecom expansion—boosting growth while reshaping real‑estate and infrastructure portfolios.